NFKB1 and osteoarthritis: Studies have shown that farrerol could inhibit the AKT/NF-κB signaling pathway in LPS-stimulated human gingival fibroblasts and IL-1β-stimulated human osteoarthritis chondrocytes [23,28], and this is consistent with our results.